Tirofiban: all 47 studies that test it
Page 1 of 1. Open to participants first (15), then studies with results posted, then the rest; newest registration first within each.
- A Multicenter, Three-Arm, Open-Label, Endpoint-Blinded Randomized Controlled Trial to Evaluate the Optimal Duration of Early Tirofiban After Intravenous Thrombolysis in Acute Ischemic StrokeNot yet recruitingNCT07842185Phase 2/3
- Tirofiban Combined With Aspirin in Moderate Ischemic StrokeNot yet recruitingNCT07760922Phase 4
- Intra-Arterial Tirofiban After Complete Recanalization for Acute Intracranial Large-Vessel OcclusionNot yet recruitingNCT07537933Phase 3
- Induced Suppression of Platelet Activity in Aneurysmal Subarachnoid Hemorrhage Management-2 (iSPASM-2)Not yet recruitingNCT07493577Phase 1/2
- HR-MRI-Directed Tirofiban Therapy for Late-Window Acute Ischemic Stroke (TIAN)RecruitingNCT07379190Phase 3
- Intravenous Tirofiban After Bridging Therapy for Acute Stroke With Atherosclerotic Large Artery OcclusionNot yet recruitingNCT07335107Phase 3
- Intravenous Thrombolysis Combined With Tirofiban in Acute Ischemic StrokeRecruitingNCT07290751Phase 4
- Intravenous Tirofiban After Delayed Thrombolysis in StrokeNot yet recruitingNCT07111806Phase 3
- Endovascular Therapy Combined With Tirofiban for Intracranial Atherosclerotic Acute Ischemic StrokeRecruitingNCT07026318Not applicable
- No-Reflow in Patients With STEMI After Intracoronary Tirofiban After Opening of the TrackRecruitingNCT06966674Not applicable
- Tirofiban for the Prevention of Early Neurological Deterioration After Intravenous Thrombolysis in Acute Ischemic StrokeNot yet recruitingNCT06587347Phase 2/3
- Tirofiban for Successful Endovascular Stroke ThrombectomyNot yet recruitingNCT06373042Phase 2/3
- Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4）RecruitingNCT06319846Phase 3
- Early Tirofiban Administration After Intravenous Thrombolysis in Acute Ischemic StrokeRecruitingNCT06045156Not applicable
- Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic StrokeRecruitingNCT05604638Phase 3
- Induced Suppression of Platelets Activity in Aneurysmal SAH Management (iSPASM)CompletedNCT03691727Phase 1/2Results posted
- Tailored Use of Tirofiban for Non-ST-elevation Acute Coronary Syndrome PatientsCompletedNCT03114995Phase 4Results posted
- Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary InterventionCompletedNCT01522417Phase 2Results posted
- Comparison of Two Treatment Strategies in Patients With an Acute Coronary Syndrome Without ST ElevationTerminatedNCT00445263Phase 4Results posted
- Tirofiban After Successful MT Recanalization in AISCompletedNCT06265051Phase 2/3
- Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm RepairCompletedNCT06238115Phase 2/3
- Efficacy and Safety of Tirofiban for Patients With BAD (BRANT)CompletedNCT06037889Phase 3
- Reduction of Microembolism After the Intervention Surgery of Intracranial Aneurysms by Administration of TirofibanStatus unknownNCT05841147Phase 4
- Intravenous Tirofiban Versus Thrombolysis Before Mechanical Thrombectomy in StrokeCompletedNCT05728333Phase 2/3
- ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem LesionCompletedNCT05225961Phase 4
- A Study Evaluating the Safety and Efficacy of Tirofiban in Combination With Alteplase in Acute Ischemic StrokeStatus unknownNCT05188417Phase 2
- One Pass Tirofiban In Management of Ischemic Stroke Thrombectomy In ChinaCompletedNCT04851457Phase 2
- Clinical Trial to Evaluate the Safety of Continuous IV Tirofiban in Acute Ischemic StrokeWithdrawnNCT04818944Phase 1/2
- Tirofiban for the Prevention of Neurological Deterioration in Acute Ischemic StrokeStatus unknownNCT04491695Phase 2/3
- Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19CompletedNCT04368377Phase 2
- Early Initiation of Low Dose Tirofiban for PPCI in STEMI Patients.Status unknownNCT03797729Phase 4
- Prevention of Coronary Slow Flow or No-Reflow During EPCI in Patients With Acute STEMIStatus unknownNCT03406832Not applicable
- Prevention of Coronary Slow Flow or No-Reflow During PPCI in Patients With Acute STEMIStatus unknownNCT03406819Not applicable
- Tirofiban for Patients Treated With AlteplaseTerminatedNCT03357133Phase 2/3
- Efficacy and Safety of Different Dose of Tirofiban in Interventional Treatment of Complex Coronary Artery DiseaseStatus unknownNCT02294994Phase 4
- Intracoronary Tirofiban on No-Reflow PhenomenaCompletedNCT02054000Phase 4
- Pharmacokinetic Evaluation of Tirofiban Using a Single High-Dose Bolus In Subjects With Varying Degrees of Renal FunctionCompletedNCT01766154Phase 1
- Tirofiban in Stenting for Long Coronary LesionCompletedNCT01498003Phase 4
- Aggrastat Truncated Length Against Standard Therapies in Percutaneous Coronary InterventionWithdrawnNCT01245725Phase 3
- Tirofiban Intracoronary Bolus-only Versus Intravenous Bolus Plus Infusion in STEMI PatientsCompletedNCT01109134Phase 3
- The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial InfarctionCompletedNCT00611169Phase 4
- Safety of High-dose Tirofiban During Coronary AngioplastyCompletedNCT00566891Phase 4
- GPIIbIIIa Inhibitors in the RESCUe and RESURCOR Networks at the Acute Myocardial InfarctionCompletedNCT00538317Phase 4
- The Effects of Tirofiban in Diabetic Patients Undergoing Elective Percutaneous Coronary InterventionStatus unknownNCT00407771Phase 4
- Study of Tirofiban Administration in Patients With Aspirin and or Clopidogrel ResistanceCompletedNCT00398463Phase 4
- FATA: Randomized Study on Facilitated Angioplasty With Tirofiban or AbciximabCompletedNCT00383136Phase 4
- Treating Acute MI Patients With Aggrastat on Their Way to HospitalStatus unknownNCT00300833Phase 4